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Abstract
Objective: To investigate if APOE E4 allelic status is associated with the cognitive functioning 
of elderly individuals. Methods: Participants (n = 1,408) from the Bambuí Cohort Study of Aging 
were selected based on the results from both variables (APOE genotype and MMSE score). 
Gender, age, education, marital status, skin color, GHQ score and biological measures were 
used as confounding factors for adjusting the logistic regression. Results: The population was 
in Hardy-Weinberg equilibrium, and the APOE E4 allele frequency was 13.4%. APOE E4 allele 
homozygosity conferred a superior odds ratio (OR) for cognitive impairment (OR = 3.1) compared 
to E4 allele heterozygosity (OR = 0.99) even when adjusted for age, sex, education, marital 
status, skin color, triglycerides, HDL, systolic pressure, and GHQ (OR = 2.9). No differences 
were observed between the other covariates. Conclusions: The APOE E4 allele was observed to 
have a dramatic effect on cognitive impairment, especially in homozygotes, which comprised 
approximately 2% of the population.
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Homozigose para o alelo E4 do gene APOE está associada à função cognitiva de idosos 
vivendo em comunidade – Projeto Bambuí
Resumo
Objetivo: Demonstrar que a presença do alelo APOE E4 está associada ao declínio cognitivo em 
idosos vivendo em comunidade. Método: Participaram do estudo 1408 residentes na cidade de 
Bambuí (MG) com 60 ou mais anos de idade. A variável dependente do estudo foi a função cognitiva, 
mensurada pelo Mini Exame do Estado Mental (MEEM). A variável de interesse do estudo foi o 
genótipo da apolipoproteína E (APOE). Para efeito de ajustamento na regressão logística foram 
consideradas como covariáveis o sexo, escolaridade, cor da pele, estado civil, sintomas 
depressivos, dosagem de triglicerídeos, HDL e pressão sistólica. Resultados: A frequência alélica 
do gene APOE (E4, E3, E2) mostrou distribuição em equilíbrio de Hardy-Weinberg. Foi detectada 
uma forte associação entre a presença do alelo E4 e o comprometimento cognitivo quando 
em homozigose (OR: 3,1; IC 95%: 1,39–6,99) mesmo após ajustamento por todas as potenciais 
variáveis de confusão (OR: 2,9; IC95%: 1,15–7,71). Conclusões: Os resultados mostraram que 
existe uma forte associação entre a presença do alelo E4 da APOE e a função cognitiva em idosos. 
Esta associação existiu somente entre indivíduos homozigotos (E4E4), indicando dependência 
da dose gênica no comprometimento cognitivo.
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Introduction
Polymorphisms of the apoliprotein E gene (APOE) are 
one of the most important and well-replicated genetic 
risk factors for Alzheimer’s disease (AD).1 ApoE is a 299 
amino acid plasma glycoprotein that plays a major role 
in lipid metabolism and is directly involved in amyloid 
plaque formation in the human brain. Two polymorphisms 
in the APOE coding region result in three alleles, APOE 
E2, APOE E3 (the most common allele) and APOE E4, 
and three major isoforms of the protein, each having 
different properties. Pooled results from association 
studies demonstrated that APOE E4 carriers have a 
3- to 4-fold increased risk of developing AD, in contrast 
to the 10- to 12-fold increase that is observed for APOE 
E4 homozygotes.2 There is also currently interest in the 
role of APOE E4 as a risk factor for cognitive performance 
in cognitively intact subjects.3-5 However, the results of 
these studies are contradictory; some show an increased 
risk for cognitive decline in association with the allele 
status, and some show no association.6,7 Brazilian stud-
ies have focused primarily on the relationship between 
the APOE gene and pathological cognitive decline (i.e., 
Alzheimer’s disease) in individuals who were attended at 
health-service locations.8-11 Only one previous community-
based study has examined the relationship between APOE 
E4 and cognitive function. This study demonstrated a lack 
of association between the APOE E4 allele and cognitive 
impairment in cognitively intact, community-dwelling 
elderly individuals.12 
The current study aims to investigate the relationship 
between the presence of the APOE E4 allele and cognitive 
performance in a large, community-based sample of Brazilian 
elderly individuals. The study will consider several potential 
confounding factors that were previously described to be 
related with cognitive impairment.
Methods
The Bambuí Cohort Study of Aging
The analysis presented herein was performed using data from 
the Bambuí Cohort Study of Aging13 as a baseline. The Bambuí 
Cohort Study is a longitudinal, population-based study on the 
health and aging of participants aged at least 60 years from 
Bambuí, a town of 15,000 inhabitants in Minas Gerais State, 
Southeastern Brazil. A complete census was performed during 
November and December 1996 to choose the participants. Since 
1998, annual follow-ups have been performed in this population 
The Bambuí Cohort Study was approved by the Ethics 
Committee of the Oswaldo Cruz Foundation in Rio de Janeiro, 
Brazil in 1996, and the present investigation was approved 
by the Ethics Committee of the Oswaldo Cruz Foundation in 
Belo Horizonte, Brazil in 2006. All of the participants provided 
full-informed written consent.
Study participants
Of the 1,742 residents aged 60 years or more, 1606 (92.2%) 
were interviewed and 1496 (85.9%) were physically exam-
ined (blood sample, laboratory tests, physical measurement 
and electrocardiogram) according to the cohort study base-
lines. All of the participants (N = 1,408) who had either a 
cognitive status measured by Mini-Mental State Exam (MMSE) 
or blood collected for APOE genotyping were selected for 
inclusion in the present study. 
Measures
Cognitive status
The study questionnaire includes a standard Brazilian version 
of the MMSE.14. MMSE is a widely used instrument for assessing 
cognitive impairment.15 However, its application to research 
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function in clinical and epidemiological studies of cognitively 
intact individuals. In the Brazilian validation study, some 
to the target population.16 In the orientation section by 
Folstein, questions regarding the season of the year, building 
address. In the registration and recall section, the words 
used were “cat”, “tree”, and “guitar”. In the attention and 
 
and spelling “world” backward was replaced by “Maria,” 
which is more commonly used in the Brazilian culture.
17 and there 
is no consensual validated cutoff point to be used for in-
dividuals with a low education. Because a low education 
level predominated in the study population, cognitive status 
was categorized by the percentile distribution of the MMSE. 
In this study, we used the cutoff point 21/22 (out of 30) 
that corresponded to the lower quartile of the MMSE score 
distribution.18
Apoliprotein E
Genomic DNA for APOE genotyping was extracted from blood 
samples using the Wizard®
 
polymerase chain reaction (PCR), which was followed 
by digestion with HhaI and restriction fragment length poly-
morphism (RFLP) analysis as previously described.19 The DNA 
samples were subjected to PCR with the following primers: 
forward 5' TAA GCT TGG CAC GGC TGT CCA AGG A 3' and re-
verse 5' ACA GAA TTC GCC CCG GCC TGG TAC AC 3'. The PCR 
conditions were denaturation at 95°C for 5 min.; 35 cycles 
of 95°C for 1 min., 60°C for 1 min., and 70°C for 2 min.; 
yielded the following patterns: E2E2, 91 and 83 bp; E3E3, 
91, 48 and 35 bp; and E4E4, 72, 48 and 35 bp. Each of the 
heterozygote genotypes contained both sets of fragments 
from each APOE allele. 
The following variables were additionally considered in 
this study: baseline age, gender, marital status, educational 
level, skin color, HDL cholesterol, triglycerides, systolic 
blood pressure (SBP) and depressive symptoms as assessed 
by General Health Questionnaire-12 (GHQ) using a cutoff of 
the Bambuí cohort study population.20 The educational level 
was categorized as either 4 years or > 4 years of schooling. 
photographs that were representative of individuals with 
different skin colors (white, light tan, dark tan, and black). 
After a 12-hour recommended overnight fast, the levels of 
HDL cholesterol and triglycerides were determined using 
commercial kits (Boehringer Mannhein Corp., Ingelheim, 
Germany) and an automated analyzer (Eclipse Vitalab, Merck, 
Netherlands) as described previously.13 Three blood pressure 
(BP) measurements were taken on the right arm with an ap-
propriately sized cuff using a mercury sphygmomanometer. 
The BP measurements were taken early in the morning 
following a 5 min. initial rest, and they were subsequently 
taken at 2 min. intervals and after 30 min. or more from 
the last instance of caffeine intake or cigarette smoked. BP 
was considered as the arithmetic mean of the second and 
third measurements. According to the Seventh Joint National 
Committee criteria,21 the symptoms of common mental disor-
ders were assessed by General Health Questionnaire-12 (GHQ) 
20
Statistical Analysis
Unadjusted associations of APOE genotype with socio-
demographic factors, biomarkers and mental health symp-
toms were evaluated using a Pearson x2 test or ANOVA for 
categorical and continuous variables, respectively. The un-
adjusted and adjusted odds ratios (ORs) were estimated by 
using logistic regression to assess the relationship between 
the APOE genotype and cognitive impairment. The analysis 
the MMSE score and APOE
and it was then adjusted incrementally for gender, age and 
education (model 2); marital status and skin color (model 3); 
HDL, triglycerides and SBP (model 4); and GHQ score (model 
5). In addition, gender and skin color interactions with APOE 
E4 carriers were tested in model 5. All of the analyses were 
performed with the STATA software package.
Results
Of the 1,606 cohort members, those who were included in the 
present analysis were the 1,408 baseline participants from 
whom cognitive status and APOE genotyping were determined 
(145 were excluded for refusing to perform blood tests, and 
53 were excluded because they did not answer the MMSE). 
When comparing those individuals who were included in this 
analysis with those who were excluded, no difference was 
observed with respect to age (mean age = 69.0 ± 7.1 and 
69.3 ± 7.4 years, respectively; p = 0.14) or gender (60.4% 
were men and 60.0% were women; p = 0.81). 
The APOE allelic and genotypic distributions in this 
population were previously demonstrated.22 The most 
frequent allele was E3 (80.0%), which was followed by E4 
(13.5%) and E2 (6.5%); this distribution is representative 
of most western populations. The E3E3 genotype was the 
most common (63.4%), and it was followed by E3E4 (21.9%), 
E2E3 (11.5%), E4E4 (1.8%), E2E4 (1.4%), and E2E2 (0.1%). 
The allelic frequencies were within the Hardy-Weinberg 
equilibrium (p > 0.05).22
Table 1 shows the selected characteristics of the study 
population based on the presence of APOE E4. The overall 
mean MMSE score was 24.4 ± 4.7.The MMSE was lower among 
APOE E4 homozygotes when compared to the E2E4 and 
E3E4 heterozygotes. The other characteristics of the study 
APOE genotypes.
Table 2 shows the unadjusted and adjusted OR for the 
associations between the APOE E4 carriers and cognitive 
impairment. APOE -
ated with a lower MMSE score, and this association remained 
after incrementally adjusting for age, gender, education, 
marital status, skin color, and for all other potential con-
founding variables (HDL, SBP, triglycerides and GHQ score) 
(OR = 2.98; 95% CI 1.15-7.71). Allele E4 homozygosity re-
mained associated even when the participants who scored 
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Table 1 Baseline characteristics of participants by APOE genotype
CHARACTERISTICS Total Total 
n = 1,408
APOE E4 NEGATIVE 
n = 1,054
APOE E4 HETEROZYGOTE  
n = 329
APOE E4 HOMOZYGOTE 
n = 25
p value
MMSE (mean/SD) 24.4 (4.7) 24.5 (4.7) 24.6 (4.6) 21.2 (4.9) 0.001
Gender (Female) (%) 60.4 61.0 59.6 48.0 0.394
Age (mean/SD) 69.0 (7.1) 69.0 (7.0) 69.2 (7.3) 67.8 (7.0) 0.641
35.1 36.0 32.8 24.0 0.287
Marital Status (%) 0.766
1. Married 50.2 49.7 51.6 50.0
2. Single 9.8 10.3 8.6 4.2
3. Divorced 5.2 5.6 3.8 4.2
4. Widowed 34.8 34.3 36.0 41.7
Skin Color (%) 0.053
1. White 60.3 59.7 62.9 48.0
2. Light Tan 33.9 34.9 30.7 32.0
3. Dark Tan 3.5 3.3 3.6 8.0
4. Black 2.3 1.9 2.7 12.0
Triglycerides (mean/SD) 151.1 (100.2) 150.7 (102.3) 152.7 (95.2) 145.1 (74.8) 0.910
HDL (mean/SD) 49.2 (15.1) 49.3 (14.9) 48.7 (15.7) 50.0 (16.1) 0.812
Systolic Blood Pressure 
(mean/SD)
137.3 (22.6) 137.1 (23.0) 137.3 (20.7) 141.8 (28.6) 0.594
37.7 38.6 35.4 33.3 0.555
MMSE: Mini-Mental State Exam; GHQ: General Health Questionnaire-12
Table 2 Association of APOE E4 and cognitive impairment
Allele E4 Score MMSE OR (CI 95%)
Not adjusted
Adjusted for Age, Sex, 
Education
Adjusted for Age, 
Sex, Education, 
Marital Status, Skin 
Color
Adjusted for Age, 
Sex, Education, 
Marital Status, Skin 
Color, Triglycerides, 
HDL, Systolic 
Pressure
Adjusted for Age, 
Sex, Education, 
Marital Status, Skin 
Color, Triglycerides, 
HDL,Systolic Pressure, 
GHQ
0 824 207 1.0 1.0 1.0 1.0 1.0
1 255 64 0.99 (0.73 – 1.36) 0.92 (0.65 – 1.28) 0.94 (0.65 – 1.34) 0.95 (0.66 – 1.37) 0.95 (0.66 – 1.38)
2 14 11 3.12 (1.39 – 6.99) 2.99 (1.22 – 7.32 2.91 (1.13 – 7.50) 2.81 (1.09 – 7.28) 2.98 (1.15 – 7.71)
below the 5th percentile (cutoff 13/14) were removed from 
the analysis, minimizing the chance of masking the results 
with the undiagnosed AD subjects.
Although gender and skin color interactions with APOE 
-
ity between the genders (p = 0.92) or among the skin colors 
Discussion
This study provides epidemiological evidence that APOE E4 
homozygosity is associated with cognitive impairment in a 
population of Brazilian community-dwelling elderly, and the 
observed association persisted after carefully controlling for 
potential confounding variables.
evaluate the association of APOE E4 presence and cognitive 
status in a large, population-based cohort in Brazil. The 
strengths of this study include the following: (1) the use of 
an MMSE score percentile distribution in the absence 
of comparable cutoff points in the Brazilian population; 
(2) a large study population with a higher response rate 
(87.6%) of Brazilian elderly in a non-isolated population; 
(3) the adjustment for a range of potential confounders, 
including skin color, HDL and depression symptoms. The 
cross-cultural equivalence of the MMSE is concerning; 
however, to overcome this problem, we used a cultur-
ally adapted version of the MMSE that performed well in 
the studied population.23
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Although studies investigating the association of APOE E4 
carriers and cognitive status in community-living elderly are rare 
in Latin America, previous studies worldwide have suggested 
that an association exists between APOE E4 and cognitive per-
formance. In a recent meta-analysis,24 38 studies showed that 
different from non-carriers. However, the E4E4 homozygotes 
performance among APOE E4 homozygotes. Yaffe et al.25 
demonstrated in 1,750 cognitively intact, community-dwelling 
women aged 65 years and older in the United States that after 
adjusting for age, education, presence of a severe tremor, and 
depression, the MMSE reduction was 0% for individuals lacking 
APOE E4, 1.9% for APOE E4 heterozygotes, and 3.7% for APOE 
E4 homozygotes. In a cross-sectional exploratory study of 
cognitively normal residents (between 30 and 70 years of age), 
Caselli et al.26 established that memory declined on all eight 
memory measures (including MMSE) in APOE E4 homozygotes. 
Memory declined on two of the eight measures in the hetero-
zygotes, and it declined on one of eight in the non-carriers. 
Moreover, our study evaluated a larger sample than the only 
other Brazilian study12, which failed to demonstrate an as-
sociation between the APOE E4 allele and cognitive status. 
The APOE E4 allele is known to represent a genetic 
risk factor in many populations, and it is considered as the 
most important susceptibility factor for AD development. 
Heterozygous APOE E4 carriers are at a 3- to 4-fold increased 
risk of becoming demented with AD, and APOE E4 homozygotes 
are at a 10- to 12-fold increased risk of developing AD.27 In a 
recent study of a Scotland cohort longitudinal follow-up,28 the 
APOE E4 status is associated with 
-
the APOE E4 allelic status and MMSE performance. 
In conclusion, in the analyzed population, cognitive im-
pairment was associated with homozygosity of the E4 allele 
of the APOE gene but not with heterozygosity, indicating 
a likely gene dosage effect. Further studies are needed to 
evaluate the complex role of genetic markers, such as the 
APOE gene, on cognitive performance in Brazilian elderly 
individuals. Data from a prospective analysis of this popula-
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